IMRT for head and neck cancer: reducing xerostomia and dysphagia. - Wikidata - wikimedia - TriplyDB

IMRT for head and neck cancer: reducing xerostomia and dysphagia.

IMRT for head and neck cancer: reducing xerostomia and dysphagia.

http://www.wikidata.org/entity/Q37187245

about

Using PROMs to guide patients and practitioners through the head and neck cancer journey.

P2860

Q47117583-63401A60-372C-40A1-AED9-3F764BF196E4

P2860

IMRT for head and neck cancer: reducing xerostomia and dysphagia.

http://www.wikidata.org/entity/Q37187245

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on August 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

IMRT for head and neck cancer: reducing xerostomia and dysphagia.

@en

IMRT for head and neck cancer: reducing xerostomia and dysphagia.

@nl

type

label

IMRT for head and neck cancer: reducing xerostomia and dysphagia.

@en

IMRT for head and neck cancer: reducing xerostomia and dysphagia.

@nl

prefLabel

IMRT for head and neck cancer: reducing xerostomia and dysphagia.

@en

IMRT for head and neck cancer: reducing xerostomia and dysphagia.

@nl

P1433

Q37187245-09948498-C89B-476F-92CF-9098049E6A7B

P1476

Q37187245-165EA974-FE18-4D8A-B4A3-0668B3A2F218

P2093

Q37187245-83C69D48-069D-46CF-8163-EAA671A0DAF5

P275

Q37187245-596FC11A-9BEF-40F6-8F2B-548CE65FCBF2

P2860

Q37187245-0215DFA0-6883-4C1A-A37F-48BA0EF6904A

Q37187245-0BB7FB2D-E68E-4E26-A981-C1881A00CDE6

Q37187245-1163D688-DE45-4985-BAFB-552A94982618

Q37187245-1626B74F-42C5-414C-9B39-9415024BE921

Q37187245-168F0311-2DC8-4D1B-96E2-C131E76FBD46

Q37187245-19FB4FCA-B1DE-44E9-86A1-1BB526C896B5

Q37187245-1A1112AC-773F-4CC5-B4AF-1009E9F74B3A

Q37187245-1C489CFE-9F48-4F7D-A0E5-94E90B24EC66

Q37187245-210A5354-49FE-414E-A46C-EC6D8B86FA72

Q37187245-210F9568-8C23-4823-8F0F-CBFF8EBB3EC1

P304

Q37187245-DF918FB2-3461-4AE7-B92F-CA553C176A8D

P31

Q37187245-4C494B49-3C9D-4821-BFBF-B27D2FA8C25D

Q37187245-75A006BE-2994-455C-B665-27346A45FB4E

P356

Q37187245-D586C71B-A424-4EA5-9B5C-D5C891974CE2

P478

Q37187245-128ADBC2-1DD3-446F-85F0-91BEA0FA5A2D

P50

Q37187245-04172FBE-4238-4B69-BD30-6AEAC749ABE8

P5008

Q37187245-E975A341-FD02-4CE2-96DB-BDB75AA3A972

P577

Q37187245-4E40F22D-0B7D-4163-BFE8-16350BD10B98

P698

Q37187245-A0E12F09-7BC6-4310-8A08-A3DE5DD4BE0B

P921

Q37187245-36E8323D-BE5F-4B57-80F0-CC523BDE8521

Q37187245-748AE4DD-A021-4361-B8DF-A5B126776736

Q37187245-9FA48DE8-D91B-4613-ABFD-B202E07B1E66

P932

Q37187245-90D50027-549D-49BA-B489-EDD03302EF2C

P356

P1433

Journal of Radiation Research

P1476

IMRT for head and neck cancer: reducing xerostomia and dysphagia.

@en

P2093

XiaoShen Wang

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

Cancer statistics, 2010

Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck

CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC,RTOG consensus guidelines.

Dysphagia disorders in patients with cancer of the oropharynx are significantly affected by the radiation therapy dose to the superior and middle constrictor muscle: a dose-effect relationship.

Treatment techniques and site considerations regarding dysphagia-related quality of life in cancer of the oropharynx and nasopharynx.

Results of fiberoptic endoscopic evaluation of swallowing vs. radiation dose in the swallowing muscles after radiotherapy of cancer in the oropharynx.

Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival.

Sequential chemotherapy and intensity-modulated radiation therapy in the management of locoregionally advanced nasopharyngeal carcinoma: experience of 370 consecutive cases.

Multi-institutional trial of accelerated hypofractionated intensity-modulated radiation therapy for early-stage oropharyngeal cancer (RTOG 00-22).

Intensity-modulated chemoradiotherapy aiming to reduce dysphagia in patients with oropharyngeal cancer: clinical and functional results.

P304

i69-i75

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/JRR/RRW047

http://www.w3.org/2001/XMLSchema#string

P478

57 Suppl 1

http://www.w3.org/2001/XMLSchema#string

P50

Avraham Eisbruch

P5008

P577

2016-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27538846

http://www.w3.org/2001/XMLSchema#string

P921

head and neck cancer

computer-assisted therapy

P932

4990117

http://www.w3.org/2001/XMLSchema#string